Laddar...
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
The epithelial cell adhesion molecule (EpCAM), or CD326, was one of the first cancer associated biomarkers to be discovered. In the last forty years, this biomarker has been investigated for use in personalized cancer therapy, with the first monoclonal antibody, edrecolomab, being trialled in humans...
Sparad:
| I publikationen: | Cancers (Basel) |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5789369/ https://ncbi.nlm.nih.gov/pubmed/29329202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10010019 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|